Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/29/1995 | EP0645143A1 Antiulcer agent and adhesion inhibitor for helicobacter pyroli |
03/29/1995 | EP0645142A1 A novel physiologically active substance |
03/29/1995 | EP0645140A1 Compositions for rectal administration containing benzimidazoles and fatty acid salts |
03/29/1995 | EP0645139A1 Use of (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidine-acetamide for the preparation of a medicament for the treatment of anxiety |
03/29/1995 | EP0645138A2 Pharmaceutical composition for maintaining and/or reestablishing a rate of blood platelet aggregation clone to the normal value |
03/29/1995 | EP0645137A1 Use of quinones for the manufacture of a medicament for the treatment and prevention of a allergic rhinitis |
03/29/1995 | EP0645056A1 Micromechanical thermoelectric sensor element. |
03/29/1995 | EP0644947A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
03/29/1995 | EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
03/29/1995 | EP0644933A1 Constitutive and inducible epidermal vector systems |
03/29/1995 | EP0644892A1 Inhibitors of angiotensin i chymase(s) including human heart chymase |
03/29/1995 | EP0644891A1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
03/29/1995 | EP0644890A1 Oligonucleotide-polyamide conjugates |
03/29/1995 | EP0644889A1 COMPOSITIONS AND METHODS FOR MODULATING $g(b)-AMYLOID |
03/29/1995 | EP0644886A1 3-substituted carbacephems |
03/29/1995 | EP0644885A1 Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
03/29/1995 | EP0644883A1 Enniatines and enniatine derivates used to control endoparasites |
03/29/1995 | EP0644882A1 Novel piperzinyl-bis(alkylamino)pyrimidine derivatives and process for preparing same |
03/29/1995 | EP0644880A1 1,2,3-triazole and imidazole compounds and their antitumor use |
03/29/1995 | EP0644878A1 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ b]AZEPINES AS NMDA RECEPTOR ANTAGONISTS |
03/29/1995 | EP0644877A1 Substituted-hexahydrobenzo a]phenanthridines |
03/29/1995 | EP0644869A1 Ion pairs of hypericin compounds having antiviral activity |
03/29/1995 | EP0644773A1 Anti-aids immunomodulator complex |
03/29/1995 | EP0644767A1 Veterinary rehydration product. |
03/29/1995 | EP0644765A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1 |
03/29/1995 | EP0644764A1 Lipids for epidermal moisturization and repair of barrier function |
03/29/1995 | EP0644762A1 Pyrazolopyridine compounds for the treatment of anemia |
03/29/1995 | EP0644761A1 Hydroxypyridin-4-ones for treatment of parasitical infections |
03/29/1995 | EP0644760A1 Treatments for diseases characterized by neovascularization |
03/29/1995 | EP0644759A1 Production and use of imines of porphyrins |
03/29/1995 | EP0644758A1 Use of fatty acids, e.g. z-hydroxymystic acids, as antiviral agents |
03/29/1995 | EP0644754A1 Substance that can stop bleeding in surgical, medical and dental uses/substance powder 001 that can stop bleeding during surgery, after surgery, medicine, dentistry or any bleeding due to any causes |
03/29/1995 | EP0644716A1 Medical uses of trioxolane and diperoxide compounds |
03/29/1995 | EP0569411B1 Acylamino-alkyliden-hydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases |
03/29/1995 | EP0558563B1 Anti-inflammatory compounds |
03/29/1995 | EP0535042B1 Angiotensis converting enzyme inhibitors |
03/29/1995 | EP0483370B1 Percutaneous preparation containing estradiol |
03/29/1995 | EP0346427B1 Macrocyclic compounds |
03/29/1995 | EP0332667B1 Vector for integration site independent gene expression in mammalian host cells |
03/29/1995 | CN1100756A Novel alpha-amylase inhibitor and the prepn. method and application |
03/29/1995 | CN1100728A Nucleosides and oligonucleotides having 2'-ether groups |
03/29/1995 | CN1100725A 2-amino-4-heteroaryl-1,4-dihydropyridines, processes for their preparation and their use in medicaments |
03/29/1995 | CN1100724A 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them |
03/29/1995 | CN1100721A Imidazopyridine |
03/29/1995 | CN1100719A 3-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo, zaetidines, processes for the preparation thereof and use thereof |
03/29/1995 | CN1100716A Basic ethers and process for the preparation thereof |
03/29/1995 | CN1100715A Trisubstituted cycloalkane derivatives and process for the preparation thereof |
03/29/1995 | CN1100635A Spermicide for external use |
03/29/1995 | CN1100634A Method of preventing emesis and treating sexual dyfunction using tetra hydrobenzÛCDÙ indole-6-carboxamides |
03/29/1995 | CN1100633A Chondroprotective agents |
03/29/1995 | CN1100632A Gamma-linolenic acid monomer, the prepn. method and application thereof |
03/29/1995 | CN1100631A Chondroprotective agents |
03/29/1995 | CN1028024C Method for preparation of tetrazole excitatory amino acid receptor antagonists |
03/29/1995 | CA2117394A1 Biodegradable implant precursor |
03/28/1995 | US5401879 Antidepressants, intestinal antispasmodic agents |
03/28/1995 | US5401875 2-aminocarboxylic acids and their derivatives, processes for their preparation and their use as medicaments |
03/28/1995 | US5401868 Aryloxymethylcarbonochloridate ester intermediates for use in synthesizing pro drugs and their use therefor |
03/28/1995 | US5401863 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines |
03/28/1995 | US5401853 Thiadiazole derivatives for the treatment of depressive states |
03/28/1995 | US5401851 Preparation of proline derivatives |
03/28/1995 | US5401844 Regulation of enzymes which utilize tetrahydrobiopterin or tetrahydrofolate cofactors with 6,6-disubstituted-tetrahydropteridines |
03/28/1995 | US5401841 3-vinyl-substituted |
03/28/1995 | US5401777 Use of preparations of curcuma plants |
03/28/1995 | US5401776 Use of modafinil for the treatment of urinary and fecal incontinence |
03/28/1995 | US5401775 Tri(lower alkoxy)benzene derivatives |
03/28/1995 | US5401774 Method for treating patients with precancerous lesions by administering substituted sulfonyl idenyl acetic and propionic acids and esters to patients with lesions sensitive to such compounds |
03/28/1995 | US5401773 Treating comedones |
03/28/1995 | US5401772 Heteroacetic acid derivatives |
03/28/1995 | US5401770 Antipruritic agents and antipruritic compositions thereof |
03/28/1995 | US5401766 Aminoacid derivatives, a process for their preparation, agents containing these compounds, and the use thereof |
03/28/1995 | US5401765 For treating arthritis, pain and fever |
03/28/1995 | US5401764 Hypotensive agents or cardiovascular disorders |
03/28/1995 | US5401762 Aminoalkyl-substituted thiazolin-2-ones, the preparation and use thereof |
03/28/1995 | US5401759 Administering calcium channel blockers |
03/28/1995 | US5401758 For treating ischemia |
03/28/1995 | US5401755 Related to ischemic, hypoxic or anoxic conditions, reducing brain damage |
03/28/1995 | US5401754 Agent for treating thrombosis and phosphodiesterase inhibitor |
03/28/1995 | US5401753 Substituted n-heteroaryl-1, 2-diaminocyclobutene-3, 3-diones |
03/28/1995 | US5401750 Derivatives of substituted imidazol-2-one and process for their preparation |
03/28/1995 | US5401749 Memory enhancers, cholinergic agents |
03/28/1995 | US5401748 2,14-disubstituted ergolines, their production and use in pharmaceutical compositions |
03/28/1995 | US5401747 Antitumor agents or antileukemia agents and as inhibitors of topoisomerase |
03/28/1995 | US5401744 Useful hemi-hydrate form of a cerebral function enhancing agent |
03/28/1995 | US5401743 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles the preparation and use thereof |
03/28/1995 | US5401742 Polymeric conjugate of methotrexate compound and pyran copolymer and method for the preparation thereof |
03/28/1995 | US5401741 Cream with ofloxacin for inflammation of ears |
03/28/1995 | US5401738 Benzimidazole compounds |
03/28/1995 | US5401734 Cephem compounds |
03/28/1995 | US5401733 Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol |
03/28/1995 | US5401730 Method for reducing platelet aggregation |
03/28/1995 | US5401729 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
03/28/1995 | US5401728 Containing plant oils, menthol, calcium stearate and magnesium stearate; for aiding in the transmission of nerve impulses |
03/28/1995 | US5401727 Process for enhancing the resistance of aquatic animals to disease |
03/28/1995 | US5401725 Treatment of tumors, rheumatoid arthritis and other diseases caused by vascular hyperplasia |
03/28/1995 | US5401724 Therapeutic treatment of chronic myelogenous leukemia by administration of 2-chloro-2'-deoxy adenosine |
03/28/1995 | US5401517 Cosmetic method for treatment of skin |
03/28/1995 | US5401514 Solid, fast-soluble pharmaceutical preparation containing S-(carboxymethyl)-L-cysteine and/or N-acetylcysteine |
03/28/1995 | US5401512 Antiulcer agents with 5-aminosalicylic acid with topical steroids |
03/28/1995 | US5401510 Wound healing modulators, non-steroidal antiinflammatory agents |
03/28/1995 | US5401509 Pharmaceutical compositions and methods of treatment of the cornea in conjunction with laser irradiation |